Sign in

Ametris

@actigraph.bsky.social
46 followers 77 following 60 posts

Pioneering the digital transformation of clinical research

PostsRepliesMedia
Ametris @actigraph.bsky.social · 01/10/2026
🚨 Submissions for Short Talk Opportunities at #ADDS2027 (Feb 8–10, 2027) are due tomorrow, Oct 2! Present your research on digital health technologies (DHTs), wearables, sensors, or eCOA in a 5–7 min oral presentation. Place your evidence in front of leading biopharma leaders: 🔗 hubs.la/Q04yZq3F0
000
Ametris @actigraph.bsky.social · 11/08/2026
Switching wearable sensors mid-study remains a risk for researchers, leading to potential disruption of data continuity. Our latest webinar navigates sensor upgrades without compromising longitudinal data compatibility. Access on-demand: hubs.la/Q04srP6t0 #Wearable #Sensors #AcademicResearch
001
Ametris @actigraph.bsky.social · 29/07/2026
In neuromuscular diseases like ALS and Duchenne muscular dystrophy (DMD), capturing continuous data across full disease progression can be complex. Ametris delivers a suite of digital endpoints designed for neuromuscular disorder populations. 💡Book a 30-min call: ametris.com/biotech/nmd
000
Ametris @actigraph.bsky.social · 27/07/2026
Last chance to register for our webinar tomorrow at 12pm EST: Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence Register now to receive the recording after: hubs.la/Q04qT1Sd0 #actigraphy #wearables #healthtech #data
hubs.la
Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence | Ametris
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!
011
Ametris @actigraph.bsky.social · 13/07/2026
Our team presented at this year’s International Conference on Ambulatory Monitoring of Physical Activity and Movement (ICAMPAM). Read the latest research highlights demonstrating analytical validation across physical activity measures. blog.ametris.com/measures-in-... #Wearable
blog.ametris.com
Measures in Motion: Demonstrating Analytical Validation Results at ICAMPAM 2026
Discover how Ametris validated wearable sensors for chronic heart failure and heart rate monitoring, ensuring accuracy in real-world conditions.
000
Ametris @actigraph.bsky.social · 08/07/2026
Join us for our upcoming DHM webinar on July 28: Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence Secure your spot: hubs.la/Q04nXyTL0
hubs.la
Achieving Data Compatibility and Navigating Hardware Evolution Across Sensor Generations with Confidence | Ametris
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!
000
Ametris @actigraph.bsky.social · 07/07/2026
Ametris Senior Data Scientist Michael Pettinati, PhD breaks down the monitoring landscape and makes the case for continuous wearable assessment in AFib clinical research. 👉 Read: Monitoring Atrial Fibrillation in Clinical Research: The Case for Continuous Wearable Assessment hubs.la/Q04nMyd90
hubs.la
Monitoring Atrial Fibrillation in Clinical Research: The Case for Continuous Wearable Assessment
Why does standard ECG miss atrial fibrillation in clinical trials? Because AFib is often silent and intermittent, continuous PPG and actigraphy detect paroxysmal and asymptomatic atrial fibrillation t...
000
Ametris @actigraph.bsky.social · 06/07/2026
Cardiology experts discuss how continuous digital measures are transforming cardiovascular trials – from coronary artery disease, heart failure, and oncology trials. Watch the new on-demand webinar on patient-centric cardiovascular endpoints: hubs.la/Q04nD1M-0
000
Ametris @actigraph.bsky.social · 15/06/2026
📍 ADDS 2027 is heading back to Atlanta. The Ametris Digital Data Summit returns for its fifth year at the Georgian Terrace Hotel, Feb 8-10 2027. Visit the ADDS 2027 Save the Date page to learn more and subscribe for event updates 👇 #clinicaltrials #digitalhealth adds.ametris.com/2027/save-th...
000
Ametris @actigraph.bsky.social · 15/06/2026
Join Ametris on Monday, June 29, 2026, at 12:00 PM ET to explore how sensor-enabled DHTs are transforming the future of cardiovascular research, drug development, and trial design. Webinar: ametris.com/digital-heal... #cardiology #heartfailure #wearables #healthtech
ametris.com
Building Patient-Centric Cardiovascular Endpoints with Continuous Digital Measures | Ametris
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!
000
Ametris @actigraph.bsky.social · 03/06/2026
AI is rapidly transforming clinical research. At the recent ADDS 2026 scientific conference, a focused session featuring experts & scientists showcased how AI and machine learning is advancing digital health. Sign up to watch on demand now: adds.ametris.com/2026/atlanta...
000
Ametris @actigraph.bsky.social · 01/06/2026
In our latest webinar, experts discuss how continuous remote monitoring and pre-competitive collaboration could expand safe outpatient immunotherapy administration for oncology patients. 🎥 Watch the on-demand webinar: ametris.com/digital-heal...
000
Ametris @actigraph.bsky.social · 20/05/2026
Join us on in 1 week on Wednesday, May 27th from 12-1pm EST for our next Digital Health Monthly webinar, "Scaling Access to Immunotherapy Treatments Through Pre-Competitive Collaboration: Introducing the DECODE CRS Coalition" Register here: hubs.la/Q04h6TYr0
100
Ametris @actigraph.bsky.social · 18/05/2026
With flexible monitoring approaches tailored to different study goals and operational needs, Ametris’ ActiTrack adherence solutions help study teams proactively identify risks, intervene when needed, and maximize data completeness. See our Adherence Monitoring Solutions: hubs.la/Q04h2b0M0
200
Ametris @actigraph.bsky.social · 18/05/2026
Join the Ametris team at the American College of Sports Medicine 2026 in Salt Lake City, Utah on May 26-29! If you'll be attending #ACSM2026, we'd love to discuss how our wearable technology solutions can help you achieve your research objectives. ametris.com/schedule-mee...
000
Ametris @actigraph.bsky.social · 14/05/2026
An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. Read the full announcement to learn more: blog.ametris.com/news/signant...
hubs.la
Signant Health Acquires Ametris to Create an End-to-End eCOA and Wearables Platform
This pre-competitive coalition aims to broaden access to immunotherapies by enabling remote monitoring of common adverse events like CRS.
000
Ametris @actigraph.bsky.social · 12/05/2026
In a Phase 3 LIBERTAS trial for metastatic castration-sensitive prostate cancer (mCSPC), J&J Innovative Medicine achieved nearly 90% wearable adherence over 12+ months of actigraphy monitoring using a real-time, intervention workflow. Check out our new case study: hubs.ly/Q04gcLvg0
hubs.ly
Case Study - LIBERTAS | Ametris
In this study, actigraphy devices were used for more than 12 months to continuously measure sleep quality and physical activity as objective proxies for hot flash burden.
000
Ametris @actigraph.bsky.social · 08/05/2026
In case you missed last week's webinar on Huntington’s Disease clinical research and digital health technology, watch the on-demand recording with expert-led technical insights: hubs.la/Q04f_4-30
hubs.la
Accelerating Huntington's Disease Research and Drug Development using Digital Health Technologies | Ametris
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Watch now!
000
Ametris @actigraph.bsky.social · 07/05/2026
Join us on Wednesday, May 27th for our next Digital Health Monthly webinar: Scaling Access to Immunotherapy Treatments Through Pre-Competitive Collaboration: Introducing the DECODE CRS Coalition Register now: hubs.la/Q04fRy200 #Immunotherapy #CytokineReleaseSyndrome #CRS
hubs.la
Scaling Access to Immunotherapy Treatments Through Pre-Competitive Collaboration: Introducing the DECODE CRS Coalition | Ametris
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!
000
Ametris @actigraph.bsky.social · 16/10/2025
Watch our latest #DigitalHealth Monthly Webinar on-demand to hear results from the ADDS 2025 #ALS Workshop, details about new digital measures in ALS, and an insightful panel discussion about how to unlock to potential of DHTs to advance ALS clinical trials: ametris.com/digital-heal...
000
Ametris @actigraph.bsky.social · 08/10/2025
Please join our upcoming #DigitalHealth Monthly webinar - Redefining #ALS Clinical Endpoints: Unlocking the Potential of #DHTs - where a diverse panel of stakeholders will explore strategies for advancing #digitalendpoints in ALS research: ametris.com/digital-heal...
000
Ametris @actigraph.bsky.social · 07/10/2025
Registration is now open for the Ametris Digital Data Summit 2026! 🚨 NEW THIS YEAR! For select abstracts submitted to the Scientific Poster Session, there will be an opportunity for a short oral presentation (5-7 minutes). We hope to see you in Atlanta! #ADDSATL2026 adds.ametris.com/2026/atlanta...
000
Ametris @actigraph.bsky.social · 03/10/2025
📣 We're excited to share a new article by Ametris' Chief Scientific Officer, Christine Guo: How AI-Driven Continuous Monitoring Can Improve Management of Immunotherapy-Related Cytokine Release Syndrome in Oncology Patients Read here: www.appliedclinicaltrialsonline.com/view/ai-immu...
appliedclinicaltrialsonline.com
How AI-Driven Continuous Monitoring Can Improve Management of Immunotherapy-Related Cytokine Release Syndrome in Oncology Patients | Applied Clinical Trials Online
Remote monitoring solution for cytokine release syndrome paves the way for more consistent patient care, a deeper understanding of immune responses, ultimately widening patient access to life-saving i...
000
Ametris @actigraph.bsky.social · 16/09/2025
Register for #DigitalHealth Monthly #webinar THIS THURSDAY, 9/18, to learn about #DECODE #Obesity working group focusing on evidence generation & regulatory engagement to enhance clinical programs with mature assessments of #physicalactivity ➡️https://ametris.com/digital-health-monthly/decode-obesity
000
Ametris @actigraph.bsky.social · 08/09/2025
📣 Call for Abstracts! We can't wait for the next opportunity to connect with the #digitalhealth community at #ADDSAtlanta2026 on Feb 23-25. We hope you will share your work at the Scientific Poster Session! 📆 Submit your abstract by Friday, October 31st, 2025: adds.ametris.com/2026/atlanta...
adds.ametris.com
Scientific Poster Session | ADDS Atlanta 2026
ADDS Atlanta 2026 Scientific Poster Session!
000
Ametris @actigraph.bsky.social · 03/09/2025
↪️ #ADDSBasel2025 is right around the corner! Have you secured your ticket? Connect with #digitalhealth researchers to accelerate #DHT adoption in #clinicalresearch. Spots are filling up! Reserve your ticket and register today: adds.ametris.com/2025/basel/h...
000
Ametris @actigraph.bsky.social · 20/08/2025
New publication from the National Health and #Aging Trends Study (#NHATS) reports that impairment in vision or motor function may be strong indicators of prevalent #dementia in older adults: bmcgeriatr.biomedcentral.com/articles/10....
bmcgeriatr.biomedcentral.com
Association of sensory and motor impairments with dementia: a cross-sectional analysis in US older adults - BMC Geriatrics
Background Impairments in sensory and motor function are common in older adults and have been linked with higher prevalence of dementia. However, their independent associations with dementia have not ...
030
Ametris @actigraph.bsky.social · 07/08/2025
📑 Are you applying for #grantfunding and using #actigraphy / #wearables / #digitalhealth tech in your study? Check out our new toolkit, Grant Preparation Resources for Wearable-Based Studies, where we gather commonly requested information in one place: landing.ametris.com/grant-toolkit
landing.ametris.com
Grant Toolkit | Ametris
This toolkit is designed to facilitate the application submission process by gathering information in one place for quick and convenient access.
010
Ametris @actigraph.bsky.social · 06/08/2025
🔎 Have you seen the #ADDSBasel2025 agenda yet? Watch the short video below to hear what makes ADDS such a unique opportunity to bring members of the multidisciplinary #digitalhealth community together in Basel on Sept. 12th! Learn more and register today▶️ adds.ametris.com/2025/basel/h...
000
Ametris @actigraph.bsky.social · 05/08/2025
🎥 Our latest #DigitalHealth Monthly webinar is available on-demand! Panelists discussed key points & lessons learned based on their experiences with #wearable #DHTs to help researchers submit compelling, high-impact #grantproposals. Watch here▶️https://ametris.com/digital-health-monthly/grant-toolkit
000
Ametris @actigraph.bsky.social · 17/07/2025
TRACE study found wrist-worn #actigraphy measured walking bouts in patients w/ #Pulmonary Arterial Hypertension correlate with 6MWD & physical impacts of #PAH, speaking to the utility of #digitalmeasures to monitor #exercisecapacity @pvrinstitute.bsky.social onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
Characteristics of Daily Walking Bouts as Valid and Reliable Indicators of Exercise Capacity in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)
There is a need for objective, continuous and remote assessment of exercise capacity in patients with pulmonary arterial hypertension (PAH). Using data from the TRACE study, in which 108 adult patien...
000
Ametris @actigraph.bsky.social · 16/07/2025
✨ The #ADDSBasel2025 Agenda is now available! ✨The schedule includes scientific presentations, case studies, & panels across four main session topics - #Oncology, #Neurology, #TechnicalValidation, & #RegulatoryPathways 🔗https://adds.ametris.com/2025/basel/home#agenda #DigitalHealth #DigitalData
000
Ametris @actigraph.bsky.social · 10/07/2025
Register for our #DigitalHealthMonthly webinar, Grant Planning for #Wearable-Based Research: Insights & Best Practices! We invite #academic, #publichealth, and #clinicalresearchers to join as we share lessons learned for incorporating #actigraphy into #grant applications: ametris.com/digital-heal...
ametris.com
Grant Planning for Wearable-Based Research: Insights and Best Practices | Ametris
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!
000
Ametris @actigraph.bsky.social · 25/06/2025
📣 The evolution is here: #ActiGraph is now #Ametris! Reflecting the transformation from our foundation in #actigraphy into a global #digitalhealth solutions provider. Same Team. Same Mission. Greater Impact. Read the announcement: blog.theactigraph.com/news/actigra...
010
Ametris @actigraph.bsky.social · 16/06/2025
📣 Join us for #DigitalHealthMonthly #webinar where #digitalhealth experts from Pfizer, J&J, and Novartis will discuss the unique challenges of #adherence & nuances of collecting #wearable #DHT-based data in #clinicaltrials🔗 Register here: theactigraph.com/digital-heal...
000
Ametris @actigraph.bsky.social · 10/06/2025
This new publication provides an objective validation of five generations of #ActiGraph sensors for researchers using these #wearables to measure #physicalactivity #sedentarybehavior & #sleep: All devices largely fell within established limits of agreement -> pubmed.ncbi.nlm.nih.gov/39819800/
pubmed.ncbi.nlm.nih.gov
Comparing Five Generations of ActiGraph Devices Using an Orbital Shaker - PubMed
Using an orbital shaker and criterion accelerometer, we found small differences in the raw output of five ActiGraph generations across a range of accelerations typical of free-living data. However, th...
000
Ametris @actigraph.bsky.social · 29/05/2025
This @ebiomedicine.bsky.social paper assesses & validates wrist-worn #accelerometry measures in #ALS. Peak 6-min activity - ✴️ demonstrated functional decline ✴️ captured unique aspects of disease impact ✴️ predicted smaller trial sample sizes for long-term studies www.thelancet.com/journals/ebi...
thelancet.com
Identification of passive wrist-worn accelerometry outcomes for improved disease monitoring and trial design in motor neuron disease
Wrist-worn accelerometry offers a practical solution for continuous monitoring in MND, complementing ALSFRS-R. Measures of peak performance, and specifically peak 6-min activity shows promise, potenti...
011
Ametris @actigraph.bsky.social · 28/05/2025
ActiGraph is excited to be at #ACSM2025 this week! ✳️ If you're attending the #Aging Interest Group meeting, we'll be presenting later today, Wed, 5/28 at 6:00pm in CC-C208 - please stop by the #ActiGraph table to connect about how #wearables can support your #research!
000
Ametris @actigraph.bsky.social · 21/05/2025
📣 Call for Abstracts! 📣 We invite you to submit your research using #wearable #DHTs to #ADDSBasel2025 #scientificposter session by Jul. 27th! Learn what previous presenters had to say about their experience below! More details & link to submit your #abstract: adds.theactigraph.com/2025/basel/s...
000
Ametris @actigraph.bsky.social · 15/05/2025
@jenschrack.bsky.social & colleagues recently published findings from the #NHATS study that #dementia was associated with lower volume & intensity of daily #physicalactivity, highlighting the need to consider physical activity accessibility and patterns as we age - journals.lww.com/acsm-msse/ab...
journals.lww.com
Physical Activity Patterns and Variability, Cognitive... : Medicine & Science in Sports & Exercise
S. Medicare beneficiaries. Dementia status (dementia vs. no dementia) was classified per NHATS protocol. Cognitive performance was assessed in executive function, orientation, and memory domains. Dail...
022
Ametris @actigraph.bsky.social · 29/04/2025
This @uwsom-wwami.bsky.social study explores integrating #wearables into outpatient #rehabilitation, finding 63% of clinicians prefer continuous monitoring, 60% of patients are willing to sync sensor data & clinicians favor #EHR integration for seamless workflow: www.medrxiv.org/content/10.1...
medrxiv.org
Perspectives of Key Stakeholders on Integrating Wearable Sensor Technology into Rehabilitation Care: A Mixed-Methods Analysis
Introduction Rehabilitation is facing a critical practice gap: Patients seek out rehabilitation services to improve their activity in daily life, yet recent work demonstrates that rehabilitation may b...
100
Ametris @actigraph.bsky.social · 23/04/2025
Visit our 📚 Patient-Focused #DigitalMeasures Library to learn how #wearable #DHTs can capture data on the functions that patients' report are most impacted by #respiratory disease symptoms, including #physicalactivity, #sleep, #cough & #vitalsigns 🔗 theactigraph.com/patient-focu...
theactigraph.com
Patient-Focused Digital Measures Library | ActiGraph
This library of FDA-based reports aims to improve understanding of key symptoms in patients and how they can be measured with medical-grade wearable DHTs.
000
Ametris @actigraph.bsky.social · 22/04/2025
Please join #ActiGraph & @hyfe.com for the upcoming #DigitalHealth Monthly #webinar discussing a new #wearable solution for #cough monitoring in the real world! Don't miss this opportunity to gain insights into cutting-edge #respiratorydisease research. 👉 Register: theactigraph.com/digital-heal...
theactigraph.com
DHM Webinar: The Value of Continuous Cough Monitoring | ActiGraph
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!
011
Ametris @actigraph.bsky.social · 16/04/2025
Researchers report higher #wearable -measured daily step count is associated with better #asthma control independent of sedentary time, suggesting interventions should focus on increasing #physicalactivity in this Journal of Clinical Allergy & Immunology paper - pubmed.ncbi.nlm.nih.gov/38492665/
pubmed.ncbi.nlm.nih.gov
Physical Activity and Sedentary Behavior as Treatable Traits for Clinical Control in Moderate-to-Severe Asthma - PubMed
Our results show that ≥7500 steps/day is associated with better asthma control independent of sedentary time in adults with moderate-to-severe asthma. Physical inactivity, anxiety, and depression symp...
000
Ametris @actigraph.bsky.social · 15/04/2025
"From the studies reviewed, a consistent theme emerges: #actigraphy serves as a powerful, minimally invasive tool to capture changes in #sleep architecture among individuals living with #psoriasis." Learn more in this new systematic review: link.springer.com/article/10.1...
link.springer.com
Actigraphy, a valuable tool for objective sleep evaluation in psoriasis: a review - Archives of Dermatological Research
Psoriasis, a form of chronic inflammatory skin disease, shows wide variations in severity and comorbidities. Considering the relatively clear scientific evidence concerning its great physical and psyc...
010
Ametris @actigraph.bsky.social · 09/04/2025
#Digitalhealth tech can transform how we measure symptoms to help researchers capture more accurate, comprehensive, & real-world view of health, including a symptom that is often overlooked & under researched – #cough. Read more in this new paper from @hyfe.com: www.nature.com/articles/s41...
nature.com
Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study - Scientific Reports
Scientific Reports - Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study
021
Ametris @actigraph.bsky.social · 03/04/2025
#Sleep is a critical aspect of health. #Wearables are effective, non-invasive tools for real-world assessments. This poster from the #ActiGraph science team leverages #NHANES data for an automated approach to detect outlier sleep periods; improving QC & uncovering new sleep insights: bit.ly/3RzyOIw
010
Reposted by Ametris
Alfonso Abecia 🐑 @alfonsoabecia.bsky.social · 27/03/2025
Our latest paper using @actigraph.bsky.social accelerometers and @staroddi.bsky.social biologgers in Comparative Biochemistry & Physiology Part A
122
Ametris @actigraph.bsky.social · 25/03/2025
A recent Phase 2 study in #cancer #cachexia reported increased body weight, improved appetite, and increased #digitalmeasures of #physicalactivity. #Wearables captured key evidence to help evaluate the impact of a possible new treatment in this multifaceted condition - www.nejm.org/doi/full/10....
nejm.org
Ponsegromab for the Treatment of Cancer Cachexia | NEJM
Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a circulating cytokine, is elevated in cancer ...
010
Ametris @actigraph.bsky.social · 20/03/2025
Despite a robust pipeline in #Parkinsonsdisease and #Alzheimersdisease, many treatments fail to go from Ph 2 to Ph 3 trials – are treatments ineffective, or are current efficacy measures not sensitive enough? Learn how #digitalhealth tech can help address this: theactigraph.com/digital-heal...
theactigraph.com
DHM Webinar: Accelerate Neurology Drug Development | ActiGraph
Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!
020